Clinical trial screening questions for seniors and families in Los Angeles. Educational navigation only; study details must be confirmed by the research team.
Potential Compensation
Study Duration
Study Location
Type 2 diabetes research studies may help researchers evaluate new ways to monitor blood sugar, support diabetes care, and understand how investigational approaches work for different people. If you are living with Type 2 diabetes, All Seniors Foundation can help you ask the right questions before deciding whether to continue with a clinical trial screening.
This page is an educational screening guide, not a promise of enrollment or medical advice. Study availability, eligibility requirements, visit schedules, compensation, and procedures must be confirmed by the research team during formal screening and informed consent.
A coordinator may ask about your diagnosis, current medications, A1C history, blood sugar monitoring, other medical conditions, and whether you can attend the required study visits. Some studies include lab work, vital signs, medication review, electrocardiogram testing, continuous glucose monitoring, or questionnaires about daily diabetes management.
Before joining any study, you should receive clear information about the purpose of the research, possible risks, possible benefits, privacy practices, visit expectations, and whether study-related care or compensation is available.
Our team can help you prepare for a screening call, organize your medication list, gather recent A1C or glucose information if available, and understand what to ask before deciding whether a study is right for you. We encourage seniors and families to involve their primary care doctor or diabetes clinician before making decisions about research participation.
Before asking about Type 2 diabetes clinical trial screening, it helps to write down your current diabetes medications, recent A1C results if you have them, how often you check blood sugar, and whether you use insulin, pills, or a continuous glucose monitor. You can also note recent low blood sugar episodes, hospital visits, kidney or heart conditions, and any transportation limits that could affect study visits.
Bringing this information to the first conversation helps the coordinator explain which questions matter most and whether a formal screening appointment may be appropriate. It also helps you compare the time commitment with your regular doctor visits, pharmacy schedule, family support, and daily routine.
If the study sounds like a possible fit, ask for the next step in writing, including visit location, approximate visit length, required testing, contact information, and whether your personal clinician should review anything before you continue. If the study is not a fit, you can still ask whether there are other diabetes research opportunities or community resources that may better match your needs.
For general research education, review the ClinicalTrials.gov guide to clinical studies and the NIH Clinical Research Trials and You resource. These explain informed consent, possible risks and benefits, and questions to ask before joining a study.
Call All Seniors Foundation or submit the screening inquiry form to ask whether Type 2 diabetes research screening is currently available. A screening conversation does not obligate you to enroll.
A screening call helps you understand the study, possible time commitment, informed consent process, and whether the research team may be a fit for your situation.
Some studies may provide compensation for completed study visits, travel, or time, depending on the protocol and eligibility.
Study-related visits are reviewed by trained research staff, with screening steps designed to protect participant safety.
Volunteers help researchers answer important health questions that may improve care options in the future.
A coordinator can explain what is required before you decide whether to continue with formal screening.
You can ask questions about visits, risks, possible benefits, privacy, and what participation would involve.
Participation is voluntary, and the research team should explain consent, withdrawal, and next steps before enrollment.
These points are only a starting guide. Final eligibility, availability, and enrollment decisions are confirmed by the study team.
Study openings, screening windows, and eligibility requirements can change.
No-obligation inquiry. Participation is voluntary and depends on formal screening.
Get answers to common questions before deciding whether to ask about formal screening
The screening team may review your diagnosis, medications, A1C history, medical conditions, and ability to attend study visits. Formal eligibility is confirmed only after the research team reviews the study criteria.
Do not stop or change diabetes medication unless your personal clinician or the study team gives clear instructions. The informed consent process should explain how current medications are handled.
Depending on the protocol, screening may include blood tests, vital signs, medication review, glucose monitoring, EKG testing, and diabetes questionnaires. The study team should explain which tests apply before enrollment.
Some studies test investigational treatments, while others compare approved approaches or monitoring methods. Ask the research team whether the study treatment is investigational and what alternatives are available.
Clinical research participation is voluntary. The consent materials should explain how withdrawal works and who to contact if you decide not to continue.
Clinical research should be reviewed, explained clearly, and built around informed consent, privacy, and participant choice.
Drug and device studies may follow applicable FDA and research oversight requirements.
Institutional review boards help evaluate participant protections and informed consent materials.
The study team should explain how personal and health information is collected, used, and protected.
You can ask questions, review consent materials, and decide whether participation is right for you.
Contact All Seniors Foundation to ask whether screening is available and what questions to prepare before speaking with the study team.
(818) 581-4101
Available 8 AM - 6 PM, Mon-Sun
16101 Ventura Blvd Suite 300
Encino, CA 91436
